| Product Name | MF | CAS | Details |
|---|
| 2-Butylcyclopentanone | C9H16O | 934-42-9 | Details |
| N-Methyl-5,6,7,8-tetrahydroquinolin-4-amine | C10H14N2 | 2059949-83-4 | Details |
| 2-[3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl]acetic acid | C17H13FN2O2 | 70598-11-7 | Details |
| 2-Methyl-2,3-dihydro-1H-indole-7-carbonitrile | C10H10N2 | 1391031-39-2 | Details |
| 2-(3-Bromopyridin-2-yl)acetonitrile | C7H5BrN2 | 122851-60-9 | Details |
| 7-Fluorooxindole | C8H6FNO | 71294-03-6 | Details |
| 6-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid | C9H7ClN2O2 | 138642-96-3 | Details |
| 4-(1H-1,2,3-Triazol-1-yl)aniline | C8H8N4 | 16279-88-2 | Details |
| Calcium hydroxide | CaH2O2 | 1305-62-0 | Details |
| KLHDC8B Blocking Peptide | Details |
| 3,3,6-Trimethyl-1,2,3,4-tetrahydroisoquinolin-1-one | C12H15NO | 1820736-06-8 | Details |
| cis-5-Tetradecenoic acid | C14H26O2 | 5684-70-8 | Details |
| 2-Ethylcyclohexanone | C8H14O | 4423-94-3 | Details |
| 3-cyano-1h-indole-7-carboxylic acid | C10H6N2O2 | 443144-25-0 | Details |
| TC-2153 hydrochloride | C7H5ClF3NS5 | 1381769-23-8 | Details |
| 2-chloro-n-[3-(trifluoromethyl)phenyl]acetamide | C9H7ClF3NO | 351-38-2 | Details |
| STATH Blocking Peptide | Details |
| PCSK6 Blocking Peptide | Details |
| NVP TAE 226 | C23H25ClN6O3 | 761437-28-9 | Details |
| PDXDC1 antibody | Details |
| Scutebarbatine B | C33H35NO7 | 905929-95-5 | Details |
| DENND1A Blocking Peptide | Details |
| HKR2 antibody | Details |
| 1-(2-(2-chlorophenoxy)acetyl)-4-(4-methoxyphenyl)thiosemicarbazide | C16H16ClN3O3S | 91543-59-8 | Details |
| 4,5-Dimethoxy-2-(2-methylpropanamido)benzoic acid | C13H17NO5 | 405898-41-1 | Details |
| 2,6-Dimethyl-4H-pyran-4-thione | C7H8OS | 1004-37-1 | Details |
| EPHA2/5 antibody (Tyr594) | Details |
| 4-Cyclopropyl-2-ethynyl-1,3-thiazole | C8H7NS | 211940-15-7 | Details |
| Methyl 2-chloro-5-(piperidine-1-sulfonyl)benzoate | C13H16ClNO4S | 415701-81-4 | Details |
| Disperse Red 60 | C20H13NO4 | 17418-58-5 | Details |
| Granzyme H Blocking Peptide | Details |
| 5-Benzyl L-glutamate N-carboxyanhydride | C13H13NO5 | 3190-71-4 | Details |
| L-Phenylalanine | C9H11NO2 | 63-91-2 | Details |
| N-Benzyl-2-carbamothioylacetamide | C10H12N2OS | 102817-84-5 | Details |
| Biotin-dPEG?3-NH3+TFA- | C20H38N4O5S.C2HF3O2 | 1334172-59-6 | Details |
| 1H,4H,5H,6H,7H-Pyrazolo[4,3-c]pyridine-3-carboxylic acid hydrochloride | C7H10ClN3O2 | 1242339-11-2 | Details |
| 2-Methoxy-1-naphthaldehyde | C12H10O2 | 5392-12-1 | Details |
| NSC 117079 | C20H15N3O7S2 | 500363-63-3 | Details |
| NXNL2 antibody | Details |
| FAM55D antibody | Details |
| cis-3-Methoxycyclobutanecarboxylic acid | C6H10O3 | 552849-35-1 | Details |
| rac-2,2,2-Trifluoro-N-[(2R,3S,4S)-4-methyl-2-(trifluoromethyl)piperidin-3-yl]acetamide hydrochloride | C9H13ClF6N2O | 2174008-17-2 | Details |
| Cytokeratin 24 Blocking Peptide | Details |
| H-Ser-Phe-Leu-Leu-Arg-NH2 | C30H51N9O6 | 141923-41-3 | Details |
| 4-(4-(Trifluoromethoxy)phenyl)piperidine hydrochloride | C12H15ClF3NO | 1004618-85-2 | Details |
| 2,4-Dimethoxybenzenesulfonamide | C8H11NO4S | 51770-71-9 | Details |
| 14,15-Leukotriene d4 | C25H40N2O6S | 75290-64-1 | Details |
| 5-Ethyl-1,3-thiazole-2-carboxylate lithium(I) | C6H8LiNO2S | 1461709-32-9 | Details |
| 3-(3-fluorophenyl)-2-methylpropanoic acid | C10H11FO2 | 41201-57-4 | Details |
| 6-Ureidomethyl-5,6-dihydromorphanthridine | C16H17N3O | 1076199-50-2 | Details |
| 2-Cyclopentenyl-1-acetone | C8H12O | 105-24-8 | Details |
| 1,4,8-Trioxaspiro[4.5]decan-2-ylmethanamine | C8H15NO3 | 1018603-76-3 | Details |
| Aoa-YDVVLSFSSDSELVEAFGGNQNCLDEELKAH-NH2 | Details |
| Hexahydro-1H-4λ?-[1,2,4]thiadiazino[3,2-c][1,4]oxazine-4,4-dione | C6H12N2O3S | 2225147-51-1 | Details |
| Deltorphin | C37H52N8O10 | 122752-15-2 | Details |
| 4-Bromophenylacetylene | C8H5Br | 766-96-1 | Details |
| 3-Cyclopropyl-4-methyl-1H-pyrazole-5-carboxylic acid | C8H10N2O2 | 1867157-28-5 | Details |
| 6-Chloro-1H-pyrrolo[3,2-c]pyridin-2(3H)-one | C7H5ClN2O | 1000342-80-2 | Details |
| 3-{[(1,3-Dimethyl-1H-pyrazol-4-yl)methyl]sulfanyl}propanoic acid | C9H14N2O2S | 1006352-76-6 | Details |
| 4-(Trifluoromethyl)umbelliferyl-b-D-cellotrioside | C28H35F3O18 | 116981-90-9 | Details |
| BBS10 antibody | Details |
| 5-Chloro-2-methylpyrido[3,4-b]pyrazine | C8H6ClN3 | 556053-82-8 | Details |
| Propan-2-yl 4-(benzyloxy)-2,2-dimethylbutanoate | C16H24O3 | 1803606-21-4 | Details |
| H-YDIALVQEVR^-OH | Details |
| 5-Chloro-4-methyl-2-nitrobenzoic acid | C8H6ClNO4 | 34633-67-5 | Details |
| Asimilobine | C17H17NO2 | 6871-21-2 | Details |
| 2-[2-(Bromomethyl)-4-chlorophenoxy]acetonitrile | C9H7BrClNO | 1094373-19-9 | Details |
| Heptadecan-7-ol | C17H36O | 93658-33-4 | Details |
| 3-(3-Bromopropoxy)benzonitrile | C10H10BrNO | 37136-97-3 | Details |
| Methyl 2-amino-3-(1H-1,3-benzodiazol-1-yl)-2-methylpropanoate dihydrochloride | 2137703-17-2 | Details |
| 4-Fluoro-5-methyl-2-nitrobenzoic acid | C8H6FNO4 | 1437780-11-4 | Details |
| CD9 antibody (PE) | Details |
| 3-Amino-2-(4-chlorophenyl)quinazolin-4(3H)-one | C14H10ClN3O | 63002-70-0 | Details |
| (2S)-2-Amino-N-ethyl-N,3-dimethylbutanamide | C8H18N2O | 1308930-90-6 | Details |
| H-EKEGKISKI-OH | Details |
| Depyrazine 6,8-dinitrophenyl varenicline | C11H11N3O4 | 950781-94-9 | Details |
| 2-Bromo-6-(methoxymethyl)pyridine | C7H8BrNO | 112575-15-2 | Details |
| 2-(2-Phenylethyl)piperidin-3-ol | C13H19NO | 1822649-91-1 | Details |
| 3-Methyl-3-(sulfanylmethyl)-1λ?-thietane-1,1-dione | 2225142-47-0 | Details |
| Type A Allatostatin I | C61H94N18O16 | 123209-95-0 | Details |
| 2-Bromo-6-(piperidin-2-yl)pyridine | C10H13BrN2 | 1270424-70-8 | Details |
| H-KRGRGRPRK-OH | Details |
| 1,4-b-D-Xylotetraose decasulfate sodium salt | Details |
| 5-(((4-(4-methoxyphenyl)(2,5-thiazolyl))amino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione | C17H16N2O5S | 497060-06-7 | Details |
| 4-Chloronaphthalene-1-carbaldehyde | C11H7ClO | 5471-26-1 | Details |
| 5-((4-fluorophenyl)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione | C13H11FO4 | 23160-10-3 | Details |
| Rabbit anti Rat IgG (H + L) (rhodamine) | Details |
| N-tert-butyl-4-formylpiperazine-1-carboxamide | C10H19N3O2 | 1024540-12-2 | Details |
| tert-butyl N-(4-chloro-2-formylphenyl)carbamate | C12H14ClNO3 | 260559-52-2 | Details |
| PRMT8 Blocking Peptide | Details |
| N-(4-(4-methylphenyl)(2,5-thiazolyl))-3-pyridylformamide | C16H13N3OS | 389081-05-4 | Details |
| 2,6-Dimethyl-a-cyclodextrin >70% | C48H84O30 | 51166-72-4 | Details |
| 5-Aminoallyl 2'-deoxycytidine-5'-triphosphate lithium, 100mM aqueous solution | Details |
| 2-(Piperidin-4-yl)-4-(pyrimidin-5-yl)pyrimidine | C13H15N5 | 2059936-51-3 | Details |
| 2-(Aminomethyl)-1H-imidazole-5-carboxylic acid, 2-BOC protected | C10H15N3O4 | 867340-37-2 | Details |
| N-{[4-(Furan-2-amido)phenyl]methyl}-1H-imidazole-1-carboxamide | C16H14N4O3 | 1087784-67-5 | Details |
| tert-Butyl N-[1-(furan-2-yl)-3-methoxypropyl]carbamate | C13H21NO4 | 1443981-42-7 | Details |
| Cystatin 9 antibody | Details |
| 5,7-Dimethylisoquinoline | C11H11N | 72374-17-5 | Details |
| (2S)-2-(Ethylamino)-3-phenylpropanoic acid | C11H15NO2 | 83545-04-4 | Details |
| Product Total： Product Page： | ||||
| 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 | ||||